Poll

Poll: Do you believe biosimilars have the same efficacy as branded medications?

Author(s):

Sheryl Stevenson

Weigh in on this month's survey question. The poll will be open until December 16, 2022.

Do you believe biosimilars have the same efficacy as branded medications?

Yes
No
Unsure

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
Related Content
Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis
May 30th 2025

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis
May 29th 2025

Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis

3 Things You Should Know About Early Treatment Intervention for TED
May 30th 2025

3 Things You Should Know About Early Treatment Intervention for TED

Ocugen’s OCU410ST receives rare pediatric disease designation for the treatment of ABCA4-associated retinopathies
May 27th 2025

Ocugen’s OCU410ST receives rare pediatric disease designation for the treatment of ABCA4-associated retinopathies

Vitamin B and choline supplementation are neuroprotective in glaucoma models
May 26th 2025

Vitamin B and choline supplementation are neuroprotective in glaucoma models

© 2025 MJH Life Sciences

All rights reserved.